Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
KYMERA THERAPEUTICS INC
About KYMR
Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system with a primary focus on immunology. The Company's targeted protein degradation (TPD) platform, which is a small molecule therapeutic modality that engages the body’s natural cellular recycling system to selectively eliminate disease-causing proteins. Its immunology programs target STAT6, IRF5 and IRAK4, each of which addresses targets within validated pathways, providing the opportunity to treat a broad range of diseases. It is developing KT-621 as part of its STAT6 program, which is being evaluated in a Phase I clinical trial in healthy volunteers. It is developing KT-579, which is an investigational, first-in-class, oral IRF5, degrader being developed for the treatment of rheumatic and autoimmune diseases.
Find out what a historical investment in KYMERA THERAPEUTICS INC would be worth today using our KYMR stock calculator.
Market Capitalisation
$6.43B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
517.75K
High today
$81.42
Low today
$78.41
Open price
$78.59
52-week high
$103.00
52-week low
$28.06
Ready to start your investing journey with Stake?
Open an accountHow do I buy KYMR shares in Australia?
Buying KYMR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in KYMERA THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KYMR
What is the ticker symbol of KYMERA THERAPEUTICS INC?
The ticker symbol for KYMERA THERAPEUTICS INC is KYMR.
How much is one share of KYMR?
One share of KYMR is valued at $80.94 as of 20 May 2026.
What is the market capitalisation of KYMERA THERAPEUTICS INC KYMR?
As of 20 May 2026 KYMERA THERAPEUTICS INC has a market cap of $6.43B.
What is the 52-week high for KYMERA THERAPEUTICS INC stock?
The KYMERA THERAPEUTICS INC 52-week high stock price is $103.00.
What is the 52-week low for KYMERA THERAPEUTICS INC stock?
The KYMERA THERAPEUTICS INC 52-week low stock price is $28.06.
Can I buy KYMR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KYMR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KYMR on Stake
- Buy KYMR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of KYMR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
KYMR related stocks